Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Analysis of the therapeutic efficacy of different doses of budesonide in patients with active Crohn's ileocolitis depending on disease activity and localization.
Herfarth H, Gross V, Andus T, Caesar I, Vogelsang H, Adler G, Malchow H, Petri A, Gierend M, Schölmerich J; German/Austrian Budesonide Study Group. Herfarth H, et al. Among authors: caesar i. Int J Colorectal Dis. 2004 Mar;19(2):147-52. doi: 10.1007/s00384-003-0529-5. Epub 2003 Sep 9. Int J Colorectal Dis. 2004. PMID: 13680283 Clinical Trial.
Replacement of conventional glucocorticoids by oral pH-modified release budesonide in active and inactive Crohn's disease: results of an open, prospective, multicenter trial.
Andus T, Gross V, Caesar I, Schulz HJ, Lochs H, Strohm WD, Gierend M, Weber A, Ewe K, Schölmerich J; German/Austrian Budesonide Study Group. Andus T, et al. Among authors: caesar i. Dig Dis Sci. 2003 Feb;48(2):373-8. doi: 10.1023/a:1021900115403. Dig Dis Sci. 2003. PMID: 12643618 Clinical Trial.
21 results